Abstract:To study further the molecular mechanisms by which glutamate and dopamine interact to regulate the functions of the basal ganglia, the effects of persistently inhibiting dopamine receptors and glutamate N-methyl-D-aspartate receptors on the density of D-1 and D-2 dopamine receptors and on the level of their transcripts were examined in mouse brain. To block dopamine receptors, mice were treated with N-ethoxycarbonyr-2-ethoxy-1,2-dihydroquinoline once daily for two and six days, or were treated with fluphenazine-N-mustard once daily for five days. To block N-methyl-D-aspartate receptors, mice were treated with dizocilpine by continuous infusion with osmotic mini-pumps for two and six days. The density of D-1 and D-2 dopamine receptors was measured by receptor autoradiography, and the lever of D-1 and D-2 dopamine receptor messenger RNA was measured by in situ hybridization histochemistry. The results showed that N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blocked about 90% of both D-1 and D-2 dopamine receptors, but had no significant effect on the lever of either D-1 or D-2 dopamine receptor messenger RNA. Fluphenazine-N-mustard, which was as effective as N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in blocking D-2 dopamine receptors but had little effect on D-1 dopamine receptors, also had no significant effect on the level of D-1 and D-2 dopamine receptor messenger RNAs. By contrast, continuously infusing dizocilpine significantly decreased the levels of D-1 dopamine receptor messenger RNA in striatum, nucleus accumbens and olfactory tubercle. Dizocilpine also caused small decreases in the density of D-2 dopamine receptors, but only in posterior striatum was this decrease statistically significant. Dizocilpine slightly and transiently decreased the levels of D-1 dopamine receptor messenger RNA in striatum but had no significant effect on the density of D-1 dopamine receptors in any region examined.This study demonstrates that persistent blockade of D-1, and D-2 dopamine receptors has relatively little effect on the levels of D-1 and D-2 dopamine receptor messenger RNA, but that blockade of N-methyl-D-aspartate receptors produces a rapid and profound decrease in the levels of D-2 dopamine receptor messenger RNA and a smaller decrease in the density of D-2 dopamine receptors. These results suggest that N-methyl-D-aspartate receptors play an important role in the expression of D-2 dopamine receptors in basal ganglia.

Neuronal Localization and Modulation of the D2 Dopamine Receptor Mrna in Brain of Normal Mice and Mice Lesioned with 6-Hydroxydopamine

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques

Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.

Comparison of the Distributions of D1 and D2 Dopamine Receptor Mrnas in Rat Brain.

In Vivo Administration of an Oligodeoxynucleotide Antisense to the D2 Dopamine Receptor Messenger RNA Inhibits D2 Dopamine Receptor-Mediated Behavior and the Expression of D2 Dopamine Receptors in Mouse Striatum.

Subcellular localization of D2 receptors in the murine substantia nigra

Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.

Dopamine-Receptor Blockade Increases Dopamine D-2 Receptor And Glutamic-Acid Decarboxylase Messenger-Rnas In Mouse Substantia-Nigra

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

Enhanced De Novo Neurogenesis And Dopaininergic Neurogenesis In The Substantia Nigra Of 1-Methyl-4-Phyenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson'S Disease-Like Mice

Unilateral Lesion of the Nigrostriatal Pathway Induces an Increase of Neuronal Firing of the Midbrain Raphe Nuclei 5-HT Neurons and a Decrease of Their Response to 5-HT(1A) Receptor Stimulation in the Rat.

Studies on Reaction of Spinal D1 and D2 Receptor Positive Neurons after 6-OHDA Lesion in Rats

Alterations in Dopamine Release but Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice

Assessment Of Dopamine D3 Receptor Function Using D3 Receptor Knockout Mice

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Dopamine D1 Receptor Mutant Mice Are Deficient in Striatal Expression of Dynorphin and in Dopamine-Mediated Behavioral Responses

Alterations In Dopamine Neurotransmission Produced By Genetic Knockouts Of Dopamine D1 Receptors

Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice.

Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: resistance to differential rearing conditions

D-2 Dopamine-Receptor Messenger-Rna Is Altered To A Greater Extent By Blockade Of Glutamate Receptors Than By Blockade Of Dopamine-Receptors